Published in Cancer Res on December 15, 1996
MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res (2009) 2.93
Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proc Natl Acad Sci U S A (2000) 2.92
The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol (2004) 2.74
Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer (2012) 2.71
Contextual synthetic lethality of cancer cell kill based on the tumor microenvironment. Cancer Res (2010) 2.68
Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A (2000) 2.61
Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A (2002) 2.39
The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion. Cancer Res (2011) 2.21
Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol (2003) 2.12
Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol (2004) 2.09
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer (2007) 1.84
Causes and effects of heterogeneous perfusion in tumors. Neoplasia (1999) 1.76
Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription. Sci Signal (2012) 1.56
Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys (2007) 1.55
Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity. Radiat Res (2015) 1.53
Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc Natl Acad Sci U S A (2010) 1.47
Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol Pharm (2011) 1.42
BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functions. Oncogene (2008) 1.32
Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation. Cancer Cell (2008) 1.27
Werner protein protects nonproliferating cells from oxidative DNA damage. Mol Cell Biol (2005) 1.26
Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis (1998) 1.23
Relationship of hypoxia to metastatic ability in rodent tumours. Br J Cancer (2001) 1.15
Nanopreparations to overcome multidrug resistance in cancer. Adv Drug Deliv Rev (2013) 1.14
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Res (2004) 1.14
Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol (2011) 1.13
Invited review: decoding the microRNA response to hypoxia. Pflugers Arch (2011) 1.12
Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer Res (2008) 1.07
Regulation of cancer metastasis by stress pathways. Clin Exp Metastasis (2003) 1.07
Hypoxia and VEGF mRNA expression in human tumors. Neoplasia (2002) 1.06
Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed (2011) 1.06
Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis. J Extracell Vesicles (2015) 1.02
Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. PLoS One (2011) 1.02
Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival. Proc Natl Acad Sci U S A (2007) 0.98
Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer (2006) 0.97
Role of pHi, and proton transporters in oncogene-driven neoplastic transformation. Philos Trans R Soc Lond B Biol Sci (2014) 0.97
Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice. Neoplasia (1999) 0.95
Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors. Radiat Res (2008) 0.94
Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol (2008) 0.94
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis. Br J Cancer (2005) 0.94
The yeast environmental stress response regulates mutagenesis induced by proteotoxic stress. PLoS Genet (2013) 0.94
Elevated CAIX Expression is Associated with an Increased Risk of Distant Failure in Early-Stage Cervical Cancer. Biomark Insights (2008) 0.94
Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment. DNA Repair (Amst) (2015) 0.93
Tumor hypoxia and genetic alterations in sporadic cancers. J Obstet Gynaecol Res (2011) 0.93
Tumor-Derived Cell Lines as Molecular Models of Cancer Pharmacogenomics. Mol Cancer Res (2015) 0.93
Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer. Asian J Androl (2014) 0.92
Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model. Am J Pathol (2000) 0.92
Tumor hypoxia as a driving force in genetic instability. Genome Integr (2013) 0.92
Aberrant methylation and associated transcriptional mobilization of Alu elements contributes to genomic instability in hypoxia. J Cell Mol Med (2010) 0.91
The tumor microenvironment and DNA repair. Semin Radiat Oncol (2010) 0.91
Anoxic fibroblasts activate a replication checkpoint that is bypassed by E1a. Mol Cell Biol (2003) 0.90
Silencing of the DNA mismatch repair gene MLH1 induced by hypoxic stress in a pathway dependent on the histone demethylase LSD1. Cell Rep (2014) 0.88
Tumors of DNA mismatch repair-deficient hosts exhibit dramatic increases in genomic instability. Proc Natl Acad Sci U S A (1998) 0.87
The role of cell density and intratumoral heterogeneity in multidrug resistance. Cancer Res (2013) 0.86
Essential role of DNA base excision repair on survival in an acidic tumor microenvironment. Cancer Res (2009) 0.86
Hypoxia and DNA repair. Yale J Biol Med (2013) 0.86
Tumor environmental factors glucose deprivation and lactic acidosis induce mitotic chromosomal instability--an implication in aneuploid human tumors. PLoS One (2013) 0.86
Janus-faced tumor microenvironment and redox. Antioxid Redox Signal (2014) 0.85
Diminished carcinogen detoxification is a novel mechanism for hypoxia-inducible factor 1-mediated genetic instability. J Biol Chem (2010) 0.85
Hypoxia--implications for pharmaceutical developments. Sleep Breath (2010) 0.84
Molecular and cellular processes underlying the hallmarks of head and neck cancer. Eur Arch Otorhinolaryngol (2012) 0.84
Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain. Gut Microbes (2015) 0.83
Oxygen tension regulates the expression of ANK (progressive ankylosis) in an HIF-1-dependent manner in growth plate chondrocytes. J Bone Miner Res (2009) 0.83
Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia. PLoS One (2014) 0.82
Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer. Sci Rep (2015) 0.82
Molecular targeting of liposomal nanoparticles to tumor microenvironment. Int J Nanomedicine (2012) 0.82
Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. BMC Cancer (2008) 0.81
Hypoxia/reoxygenation-induced mutations in mammalian cells detected by the flow cytometry mutation assay and characterized by mutant spectrum. Radiat Res (2010) 0.81
Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines. Biomed Res Int (2013) 0.79
Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins. Mol Cancer Res (2014) 0.79
Hypoxia represses microRNA biogenesis proteins in breast cancer cells. BMC Cancer (2014) 0.79
Intraoperative blood loss independently predicts survival and recurrence after resection of colorectal cancer liver metastasis. PLoS One (2013) 0.79
Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression. CPT Pharmacometrics Syst Pharmacol (2014) 0.78
Tumor antigens as proteogenomic biomarkers in invasive ductal carcinomas. BMC Med Genomics (2014) 0.78
Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis. PLoS One (2015) 0.75
Hypoxia Strongly Affects Mitochondrial Ribosomal Proteins and Translocases, as Shown by Quantitative Proteomics of HeLa Cells. Int J Proteomics (2015) 0.75
Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids. PLoS One (2011) 0.75
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer. J Pathol Inform (2016) 0.75
Stabilization of HIF-1α and HIF-2α, up-regulation of MYCC and accumulation of stabilized p53 constitute hallmarks of CNS-PNET animal model. PLoS One (2017) 0.75
In vitro anti-cancer activity of doxorubicin against human RNA helicase, DDX3. Bioinformation (2016) 0.75
Hypoxia alters the recruitment of tropomyosins into the actin stress fibres of neuroblastoma cells. BMC Cancer (2015) 0.75
Acid-mediated tumour cell invasion: a discrete modelling approach using the extended Potts model. Clin Exp Metastasis (2013) 0.75
BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol (1999) 2.79
Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair. Science (1996) 2.63
Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys (1984) 2.47
The sexual history in general medicine practice. Arch Intern Med (1984) 2.42
Detection and analysis of UV-induced mutations in mammalian cell DNA using a lambda phage shuttle vector. Proc Natl Acad Sci U S A (1986) 2.30
Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation. Mol Cell Biol (1995) 2.05
The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell (1996) 1.99
Specific mutations induced by triplex-forming oligonucleotides in mice. Science (2000) 1.98
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res (1997) 1.76
Targeted mutagenesis of DNA using triple helix-forming oligonucleotides linked to psoralen. Proc Natl Acad Sci U S A (1993) 1.69
WAG-F8(m1Ycb) rats harboring a factor VIII gene mutation provide a new animal model for hemophilia A. J Thromb Haemost (2010) 1.69
Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene (2006) 1.68
Triplex DNA: fundamentals, advances, and potential applications for gene therapy. J Mol Med (Berl) (1997) 1.54
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys (1993) 1.52
Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci U S A (1997) 1.51
Targeted gene knockout mediated by triple helix forming oligonucleotides. Nat Genet (1998) 1.51
In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy. Lab Anim Sci (1977) 1.49
Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev (1987) 1.48
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res (1998) 1.44
ATM-dependent expression of the insulin-like growth factor-I receptor in a pathway regulating radiation response. Proc Natl Acad Sci U S A (2001) 1.42
Targeted mutagenesis of simian virus 40 DNA mediated by a triple helix-forming oligonucleotide. J Virol (1993) 1.40
Triple-helix formation induces recombination in mammalian cells via a nucleotide excision repair-dependent pathway. Mol Cell Biol (2000) 1.40
Chromosomal mutations induced by triplex-forming oligonucleotides in mammalian cells. Nucleic Acids Res (1999) 1.38
Diminished DNA repair and elevated mutagenesis in mammalian cells exposed to hypoxia and low pH. Cancer Res (2000) 1.37
p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. Cancer Res (1995) 1.36
Mutagenesis by third-strand-directed psoralen adducts in repair-deficient human cells: high frequency and altered spectrum in a xeroderma pigmentosum variant. Proc Natl Acad Sci U S A (1996) 1.34
Triplex forming oligonucleotides: sequence-specific tools for gene targeting. Hum Mol Genet (2001) 1.34
Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc Natl Acad Sci U S A (1999) 1.32
Mutagenesis induced by the tumor microenvironment. Mutat Res (1998) 1.29
Recombination induced by triple-helix-targeted DNA damage in mammalian cells. Mol Cell Biol (1996) 1.27
Repair of potentially lethal damage in vivo in solid tumor cells after x-irradiation. Cancer Res (1974) 1.27
Targeted correction of an episomal gene in mammalian cells by a short DNA fragment tethered to a triplex-forming oligonucleotide. J Biol Chem (1999) 1.27
Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res (1973) 1.25
The hypoxic tumor cell: a target for selective cancer chemotherapy. Biochem Pharmacol (1980) 1.24
Altered repair of targeted psoralen photoadducts in the context of an oligonucleotide-mediated triple helix. J Biol Chem (1995) 1.22
Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol (1999) 1.22
Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells. Proc Natl Acad Sci U S A (1998) 1.21
Triplex-induced recombination in human cell-free extracts. Dependence on XPA and HsRad51. J Biol Chem (2001) 1.21
Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor. Cancer Res (1996) 1.21
DNA mismatch repair detected in human cell extracts. Mol Cell Biol (1987) 1.17
The molecular and cellular basis of radiosensitivity: implications for understanding how normal tissues and tumors respond to therapeutic radiation. Cancer Invest (1999) 1.16
Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer (1994) 1.13
The Tyr-265-to-Cys mutator mutant of DNA polymerase beta induces a mutator phenotype in mouse LN12 cells. Proc Natl Acad Sci U S A (1999) 1.11
Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents. Oncogene (1998) 1.10
Role of DNA mismatch repair in the cytotoxicity of ionizing radiation. Cancer Res (1997) 1.09
Site-specific targeting of psoralen photoadducts with a triple helix-forming oligonucleotide: characterization of psoralen monoadduct and crosslink formation. Nucleic Acids Res (1994) 1.09
High-frequency intrachromosomal gene conversion induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci U S A (2000) 1.07
Ionizing radiation-induced apoptosis via separate Pms2- and p53-dependent pathways. Cancer Res (2000) 1.07
Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. Cancer Res (1984) 1.07
Mitomycin C: a prototype bioreductive agent. Oncol Res (1994) 1.06
High efficiency, restriction-deficient in vitro packaging extracts for bacteriophage lambda DNA using a new E.coli lysogen. Nucleic Acids Res (1993) 1.05
Hypoxia-selective nitrobenzyloxycarbonyl derivatives of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazines. J Med Chem (1999) 1.04
Triplex formation by oligonucleotides containing 5-(1-propynyl)-2'-deoxyuridine: decreased magnesium dependence and improved intracellular gene targeting. Biochemistry (1999) 1.04
Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res (1980) 1.03
Chromosome targeting at short polypurine sites by cationic triplex-forming oligonucleotides. J Biol Chem (2001) 1.03
Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Cancer Res (1989) 1.01
In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer. Br J Cancer Suppl (1980) 1.01
The intracellular location of NADH:cytochrome b5 reductase modulates the cytotoxicity of the mitomycins to Chinese hamster ovary cells. J Biol Chem (1998) 1.00
A technique for determining the proportion of the clonogenic cells in S phase in ENT6 cell cultures and tumors. Cell Tissue Kinet (1976) 0.99
Potassium-resistant triple helix formation and improved intracellular gene targeting by oligodeoxyribonucleotides containing 7-deazaxanthine. Nucleic Acids Res (1997) 0.99
Peptide nucleic acid (PNA) binding-mediated induction of human gamma-globin gene expression. Nucleic Acids Res (1999) 0.98
IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol (1996) 0.97
Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci U S A (1996) 0.97
Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line. Proc Natl Acad Sci U S A (1987) 0.96
Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase. Proc Natl Acad Sci U S A (1996) 0.96
Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. J Clin Oncol (1997) 0.94
Mutagenesis by 8-methoxypsoralen and 5-methylangelicin photoadducts in mouse fibroblasts: mutations at cross-linkable sites induced by offoadducts as well as cross-links. Cancer Res (1995) 0.94
Physical examination as a screening test for pelvic fractures in blunt trauma patients. W V Med J (1997) 0.93
Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro. Int J Cancer (1986) 0.93
Frequent spontaneous deletions at a shuttle vector locus in transgenic mice. Mutagenesis (1996) 0.92
Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns. Cancer Res (1993) 0.91
Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts. J Biol Chem (1988) 0.91
Gene targeting via triple-helix formation. Prog Nucleic Acid Res Mol Biol (2001) 0.91
Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res (1985) 0.90
Evaluation of BA1112 rhabdomyosarcoma oxygenation with microelectrodes, optical spectrophotometry, radiosensitivity, and magnetic resonance spectroscopy. Magn Reson Med (1991) 0.90
Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts. Carcinogenesis (2000) 0.90
Vitamin A inhibits radiation-induced pneumonitis in rats. J Nutr (1998) 0.90
Hypermutability to ionizing radiation in mismatch repair-deficient, Pms2 knockout mice. Cancer Res (2001) 0.89
Use of a perfluorochemical emulsion to improve oxygenation in a solid tumor. Int J Radiat Oncol Biol Phys (1985) 0.89
Biological basis of radiation sensitivity. Part 2: Cellular and molecular determinants of radiosensitivity. Oncology (Williston Park) (2000) 0.89
Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells. Chem Res Toxicol (2000) 0.89
Effect of host age on the transplantation, growth, and radiation response of EMT6 tumors. Cancer Res (1981) 0.88
Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys (1989) 0.88
Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix. Int J Cancer (2000) 0.88
Radiosensitization of EMT6 cells by four platinum complexes. Int J Radiat Oncol Biol Phys (1985) 0.87
Antitumour effects of genetically engineered Salmonella in combination with radiation. Eur J Cancer (2000) 0.87
Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo. Gene Ther (2012) 0.87
Regulation of scatter factor production via a soluble inducing factor. J Cell Biol (1994) 0.87
Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy. Cancer (2000) 0.86
Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas. Int J Cancer (2000) 0.86
Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines. Intervirology (1985) 0.86
Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C. Oncol Res (1998) 0.85
Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates. Radiat Res (1990) 0.85
Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res (1985) 0.84
Applicability of animal tumor data to cancer therapy in humans. Int J Radiat Oncol Biol Phys (1988) 0.83
Growth and cell population kinetics of single and multiple KHT sarcomas. Cell Tissue Kinet (1972) 0.83
Lambda phage shuttle vectors for analysis of mutations in mammalian cells in culture and in transgenic mice. Mutat Res (1989) 0.83
Triplex-mediated, in vitro targeting of psoralen photoadducts within the genome of a transgenic mouse. Photochem Photobiol (1996) 0.83